Rho Chi Talks: Tips to Acquire a Post-Doctoral Fellowship
Featuring: Kamran Khan, PharmD Candidate c/o 2023By: Justin Budz, PharmD Candidate c/o 2023 Kamran Khan is a sixth-year pharmacy student…
Featuring: Kamran Khan, PharmD Candidate c/o 2023By: Justin Budz, PharmD Candidate c/o 2023 Kamran Khan is a sixth-year pharmacy student…
By: Brian Chung, PharmD Candidate c/o 2024, Peter Chung, PharmD Candidate c/o 2024, and Kevin Kim, PharmD Candidate c/o 2024…
Featuring: Christina Swiger, PharmD Candidate c/o 2023By: Justin Budz, PharmD Candidate c/o 2023 Christina Swiger is a sixth-year pharmacy student…
By: Geraldine Ciaccio, PharmD Candidate c/o 2025 Pregnant women treated with antidepressants may no longer have to endure the…
By: Justin Budz, PharmD Candidate c/o 2023 Diabetes mellitus encompasses both chronic and reversible conditions that affect the body’s…
By: Helen Li, PharmD Candidate c/o 2023 On June 18, 2022, Centers for Disease Control and Prevention (CDC) Director,…
Featuring: Amanda Murray, PharmD Candidate c/o 2024 and Laura Cranston, B.S.PharmBy: Ashley Dao, PharmD Candidate c/o 2024 Alumni Insider’s View…
By: Jennifer Galvet, PharmD Candidate c/o 2024 Farxiga (dapagliflozin) is a first-in-class, oral, once daily sodium-glucose cotransporter 2 (SGLT2)…
By: Sairah Sheikh, PharmD Candidate c/o 2024 Promising new research conducted by doctors at Memorial Sloan Kettering Cancer Center…
Featuring: Ali Baig, PharmD Candidate c/o 2023By: Helen Li, PharmD Candidate c/o 2023 Ali Baig is a sixth-year pharmacy student…